Ticker brief
EXEL
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
6
authors 14d
5
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-07-02 · now +0.27 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @EmmanuelInvest | C | -1.12 | 2 | +0.25 |
| @BioStocks | C | -0.39 | 1 | -0.25 |
| @OzmosiHealth | C | · | 1 | +0.00 |
| @fj_nextstage | C | +1.07 | 1 | +0.20 |
| @OptionsFlowBoss | C | · | 1 | +0.30 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-02 | @EmmanuelInvest | +0.25 | UBS raises Exelixis PT to $52, maintains Neutral. | · | tweet ↗ |
| 2026-07-02 | @OptionsFlowBoss | +0.30 | First two hours unusual bullish options volume list with multiples. | · | tweet ↗ |
| 2026-07-02 | @EmmanuelInvest | +0.25 | UBS raises Exelixis PT to $52 from $43, Neutral. | · | tweet ↗ |
| 2026-06-26 | @fj_nextstage | +0.20 | IBD50 additions after pivot breaks or 50DMA recoveries; medical shift noted. | · | tweet ↗ |
| 2026-06-22 | @OzmosiHealth | +0.00 | Exelixis provided an update on Phase 3 STELLAR-303 trial. | · | tweet ↗ |
| 2026-06-22 | @BioStocks | -0.25 | Phase 3 STELLAR-303 showed non-statistically significant OS trend favoring combination. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.